loader image
Saturday, February 24, 2024
76.7 F
McAllen
We Welcome your Press Release
- Advertisement -

Maestre selected to participate in peer review Study Section of the Center for Scientific Review

Translate to Spanish or other 102 languages!

Dr. Gladys Maestre, UTRGV professor and director of The UTRGV Alzheimer’s Disease Resource Center for Minority Aging Research (AD-RCMAR), was recently selected to serve on the Neurological, Aging and Musculoskeletal Epidemiology (NAME) Study Section of the Center for Scientific Review. Maestre will serve a four-year term ending June 30, 2025. (UTRGV Photo)

Mega Doctor News

- Advertisement -

By Maria Gonzalez 

RIO GRANDE VALLEY, TEXAS – Dr. Gladys Maestre, UTRGV professor and director of The UTRGV Alzheimer’s Disease Resource Center for Minority Aging Research (AD-RCMAR), has been selected to serve on the Neurological, Aging and Musculoskeletal Epidemiology (NAME) Study Section of the Center for Scientific Review

Maestre, professor of neurosciences and human genetics, has worked with Alzheimer’s disease and related disorders for more than 20 years. 

- Advertisement -

She said she is excited to contribute to NAME in her specialty area, especially in topics of geographic- and age-related patterns of neurological disorders in minority populations. 

“My expertise in age-related disorders in minority populations and in national or international low-resource settings could be useful as many researchers are trying to develop programs to benefit those underserved and economically challenged.  

“Also, as a Latina, I expect to contribute the unique perspective that my cultural values sustain,” she said 

Maestre will serve a four-year term ending June 30, 2025. Her scientific service in the extramural appointment will help assure the quality of the National Institutes of Health peer review process, review grant applications submitted to the NIH, and make objective recommendations that will contribute to the national biomedical research effort.  

- Advertisement -

The research designs and methodologies reviewed in NAME include cohort, case-control, prospective, longitudinal, retrospective, clinical trial, cross-sectional, surveillance and meta-analysis.  

“This appointment is very significant for me,” she said. “NAME reviews applications on epidemiologic research on neurological disorders, conditions related to aging and musculoskeletal conditions, in addition to studies of communication and visual disorders. All these topics are of utmost interest for me and allow me to be aware of the proposed innovations and solutions to limitations.” 

Dr. Ihsan M. Salloum, director of the UTRGV Institute for Neuroscience, said Maestre is doing cutting-edge research that will benefit the Valley and congratulated her on her selection to the NAME Study Section. 

“Dr. Maestre’s work focusing on Alzheimer’s disease and aging research is of high significance for the Rio Grande Valley and the Latino population, and her contributions will enhance our mission of improving the lives of persons with Alzheimer’s disease and their families – here, nationally and beyond,” he said. “This appointment is further recognition and affirmation of her standing as a scientist at the national level. Dr. Maestre is not only an outstanding scientist but a true champion and ambassador for Alzheimer’s disease.” 

Maestre said she is thankful for all the support she receives at UTRGV and expressed special gratitude to university colleague Dr. Michael Mahaney of the Department of Human Genetics. 

“He held this same position until two years ago, and I am sure that his successful participation in this Study Section created the right conditions to facilitate my nomination,” she said. 

Dr. Michael Mahaney of the UTRGV School of Medicine Department of Human Genetics and Dr. Gladys Maestre, UTRGV professor and director of The UTRGV Alzheimer’s Disease Resource Center for Minority Aging Research (AD-RCMAR). Mahaney previously served on the Neurological, Aging and Musculoskeletal Epidemiology (NAME) Study Section of the Center for Scientific Review of which Maestre was recently appointed. (UTRGV Photo)

ABOUT MAESTRE 

Maestre’s role at RGV AD-RCMAR reinforces the center’s commitments to build a community of expert researchers to reduce health discrepancies among Hispanics in South Texas through advanced research about the high numbers of Alzheimer’s and dementia cases in the Rio Grande Valley’s Latino Population.   

Maestre’s achievements in her field are a reflection of her scientific discipline as evidenced by her research projects, including the  Maracaibo Aging Study, the first longitudinal study on aging in Latin America, other significant achievements. and more than 145 publications in scientific journals. 

She began her career education in her native Venezuela, where she obtained a Doctor of Medicine (M.D.) degree at The University of Zulia in 1989. She completed her postdoctoral studies in the Department of Psychiatry at Harvard Medical School and got a Ph.D. in the Department of Pathology and Center for Neurobiology and Behavior at Columbia University in 1996. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

PSJA ISD Student Leaders Annual Track of Hope Cancer Awareness Walk, Feb. 24th 

With many members of the PSJA community affected by cancer, PSJA ISD high school students organized the Track of Hope Cancer Awareness & Relief Walk event to help raise awareness and funds to give back.

Epidemiology Expert Dr. Scott Lillibridge Takes Helm at DHR Health Institute for Research and Development

Dr. Lillibridge's distinguished federal career with the Centers for Disease Control and Prevention (CDC) includes serving as Special Assistant to the Secretary for the Department of Health and Human Services, Director for the CDC Bioterrorism Preparedness and Response Program, and Medical Director for the US Office of Foreign Disaster Assistance (USAID).

Aida Coronado Garcia’s Back to the Beginning, A Day of Leadership at Perkins Middle School     

Coronado Garcia's visit was more than just a ceremonial return; it was an interactive and insightful activity into the daily operations and challenges of running a middle school.

New Cell-Based Immunotherapy Offered for Melanoma

Washington University doctors and researchers were involved in clinical trials that led to the FDA approval.
- Advertisement -
×